Minnesota bills · 2025-2026 Regular Session
Minnesota SF 2645
Formulary Committee members with a potential conflict of interest participation in committee communications and discussions authorization provision, public comment process for recommendations to the Formulary Committee development by the commissioner of human services requirement provision, and Minnesota Rare Disease Advisory Council expertise sought by the Formulary Committee requirement provision
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Boldon (Democratic-Farmer-Labor)
Cosponsors (2)
Summary
No official summary is available for this bill.
Latest action(Mar 17, 2025): Referred to Health and Human Services
Text versions
- Introduction· Mar 14, 2025
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 17, 2025 · Senate
Referred to Health and Human Services - Mar 17, 2025 · Senate
Introduction and first reading